scholarly article | Q13442814 |
P356 | DOI | 10.1002/CPT1976195PART1508 |
P698 | PubMed publication ID | 776488 |
P2093 | author name string | J. M. Strong | |
A. J. Atkinson | |||
J. S. Dutcher | |||
W. K. Lee | |||
R. F. Kehoe | |||
P433 | issue | 5 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 508-514 | |
P577 | publication date | 1976-05-01 | |
P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
P1476 | title | Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions | |
P478 | volume | 19 |
Q28260649 | Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias |
Q52706260 | Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. |
Q46196153 | Antiarrhythmic potency of procainamide and N-acetylprocainamide in rabbits |
Q28262289 | Clinical Pharmacokinetics of N-acetylprocainamide |
Q39720665 | Clinical Pharmacokinetics of Procainamide |
Q41690934 | Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype |
Q72626194 | Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide |
Q41064424 | Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide |
Q44261205 | Drug Metabolism and Active Drug Metabolites in Renal Failure |
Q40325635 | Drug metabolites in renal failure: pharmacokinetic and clinical implications |
Q39621411 | Effect of active drug metabolites on plasma level-response correlations |
Q71397213 | Effect of procainamide on left ventricular performance in patients with primary myocardial disease |
Q72633084 | Electrophysiologic effects of N-acetylprocainamide in human beings |
Q89869342 | Elucidation of the pathophysiology of intradialytic muscle cramps: pharmacokinetics applied to translational research |
Q67353778 | Pharmacokinetic approach to intravenous procainamide therapy |
Q28329448 | Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure |
Q66704847 | Procainamide, acetylprocainamide, and drug-induced lupus erythematosus |
Q66704846 | Renal effects of tolazoline in rabbits |
Q43509787 | Serum Levels and Electrophysiological Effects of N-Acetylprocainamide as Compared with Procainamide in the Dog Heart in situ |
Q67041226 | Serum Procainamide Levels As Therapeutic Guides |
Q72722386 | Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide |
Q39533089 | Significance of the acetylation phenotype and the therapeutic effect of procainamide |
Q40282215 | The pharmacological role of the kidney |
Q40327652 | Therapeutic drug monitoring of antiarrhythmic agents |
Search more.